{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:41:41Z","timestamp":1768779701537,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cardfail.2012.01.019","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T14:02:44Z","timestamp":1331388164000},"page":"351-358","source":"Crossref","is-referenced-by-count":37,"title":["Plasma Copeptin Levels and Prediction of Outcome in Heart Failure Outpatients: Relation to Hyponatremia and Loop Diuretic Doses"],"prefix":"10.1016","volume":"18","author":[{"given":"Louise","family":"Balling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Egstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Peter","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2012.01.019_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/jcem-42-4-613","article-title":"The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man","volume":"42","author":"Robertson","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"issue":"9A","key":"10.1016\/j.cardfail.2012.01.019_bib3","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/j.amjcard.2005.03.003","article-title":"Neurohormonal activation in congestive heart failure and the role of vasopressin","volume":"95","author":"Chatterjee","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1071-9164(99)91339-8","article-title":"Vasopressin: a therapeutic target in congestive heart failure?","volume":"5","author":"Goldsmith","year":"1999","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0290001","article-title":"Vasopressin V2 receptor antagonists","volume":"29","author":"Verbalis","year":"2002","journal-title":"J Mol Endocrinol"},{"issue":"2 Pt 2","key":"10.1016\/j.cardfail.2012.01.019_bib6","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2012.01.019_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI108377","article-title":"Distribution, blood transport, and degradation of antidiuretic hormone in man","volume":"57","author":"Baumann","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2012.01.019_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cardfail.2012.01.019_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro\u2013B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cardfail.2012.01.019_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cardfail.2006.09.004","article-title":"Comparative evaluation of B-type natriuretic peptide, mid-regional pro\u2013A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure","volume":"13","author":"Gegenhuber","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib12","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","article-title":"C-Terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study","volume":"115","author":"Khan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2012.01.019_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurjhf\/hfr049","article-title":"Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure","volume":"13","author":"Tentzeris","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"12A","key":"10.1016\/j.cardfail.2012.01.019_bib14","doi-asserted-by":"crossref","first-page":"19L","DOI":"10.1016\/j.amjcard.2005.09.066","article-title":"Hyponatremia in patients with heart failure","volume":"96","author":"De Luca","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/eurjhf\/hfr086","article-title":"Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure","volume":"13","author":"Balling","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCHEARTFAILURE.111.961011","article-title":"Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia","volume":"4","author":"Madan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejheart.2004.03.016","article-title":"Prevalence and characteristics of heart failure clinics in Denmark\u2014design of the Danish Heart Failure Clinics Network","volume":"7","author":"Gustafsson","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ejheart.2007.05.008","article-title":"Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure","volume":"9","author":"Gustafsson","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2012.01.019_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0895-4356(02)00591-7","article-title":"The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry","volume":"56","author":"Madsen","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2012.01.019_bib22","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/cc9336","article-title":"Copeptin and risk stratification in patients with acute dyspnea","volume":"14","author":"Potocki","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cardfail.2012.01.019_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2012.01.019_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/eurjhf\/hfp206","article-title":"The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI\u2013Heart Failure (GISSI-HF) trial","volume":"12","author":"Masson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib26","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2011.666","article-title":"Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure","volume":"305","author":"Alehagen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2012.01.019_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCHEARTFAILURE.110.960096","article-title":"Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study","volume":"4","author":"Maisel","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2012.01.019_bib28","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2012.01.019_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/17482940701210179","article-title":"Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial","volume":"9","author":"Rossi","year":"2007","journal-title":"Acute Card Care"},{"key":"10.1016\/j.cardfail.2012.01.019_bib30","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2012.01.019_bib31","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/archinte.167.18.1998","article-title":"Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial","volume":"167","author":"Gheorghiade","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2012.01.019_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ki.1976.82","article-title":"Effects on the central nervous system of hypernatremic and hyponatremic states","volume":"10","author":"Arieff","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2012.01.019_bib33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0735-1097(86)80417-X","article-title":"Hemodynamic effects of infused arginine vasopressin in congestive heart failure","volume":"8","author":"Goldsmith","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib34","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2008010021","article-title":"Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists","volume":"19","author":"Perucca","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2012.01.019_bib35","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jacc.2011.07.032","article-title":"Biomonitoring and biomarker-guided therapy the next step in heart failure and biomarker research [editorial]","volume":"58","author":"Maisel","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916412000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916412000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T10:56:06Z","timestamp":1543143366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916412000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1071916412000425"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2012.01.019","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}